Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease characterized by the clonal expansion of malignant B cells. To predict the clinical course of the disease, the identification of diagnostic biomarkers is urgently needed. Aberrant methylation patterns may predict CLL developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Loi, Eleonora, Moi, Loredana, Fadda, Antonio, Satta, Giannina, Zucca, Mariagrazia, Sanna, Sonia, Amini Nia, Shadi, Cabras, Giuseppina, Padoan, Marina, Magnani, Corrado, Miligi, Lucia, Piro, Sara, Gentilini, Davide, Ennas, Maria Grazia, Southey, Melissa C., Giles, Graham G., Wong Doo, Nicole, Cocco, Pierluigi, Zavattari, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697638/
https://www.ncbi.nlm.nih.gov/pubmed/31452839
http://dx.doi.org/10.18632/oncotarget.27080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697638/
https://www.ncbi.nlm.nih.gov/pubmed/31452839
http://dx.doi.org/10.18632/oncotarget.27080

Ejemplares similares